Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The beta A4 amyloid protein precursor in human circulation

A I Bush1, K Beyreuther, C L Masters

  • 1Department of Pathology, University of Melbourne, Victoria Australia.

Annals of the New York Academy of Sciences
|September 24, 1993
PubMed
Summary

Alzheimer's disease involves beta-amyloid (A4) protein collections derived from amyloid precursor protein (APP). Studies of circulating APP in blood cells and plasma help understand its function and processing in health and Alzheimer's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study" [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567-581].

The journal of prevention of Alzheimer's disease·2025
Same author

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

The journal of prevention of Alzheimer's disease..·2024
Same author

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.

The journal of prevention of Alzheimer's disease·2024
Same author

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.

The journal of prevention of Alzheimer's disease·2023
Same author

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2023
Same author

Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study.

AJNR. American journal of neuroradiology·2023

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Beta-amyloid (A4) is a key component of amyloid plaques in Alzheimer's disease (AD).
  • Amyloid precursor protein (APP) is the source of beta-amyloid.
  • APP circulates in various forms within the blood.

Purpose of the Study:

  • To investigate the presence and forms of circulating amyloid precursor protein (APP).
  • To understand the role of APP in health and its processing in Alzheimer's disease.

Main Methods:

  • Analysis of APP forms in platelets, plasma, and T-lymphocytes.
  • Biochemical characterization of circulating APP species.

Main Results:

  • Full-length, potentially amyloidogenic APP found in platelets.

Related Experiment Videos

  • Attenuated forms of APP detected in plasma and T-lymphocytes.

    • Conclusions:

    • Circulating APP exists in distinct forms depending on the cell type.
    • Studying circulating APP is crucial for understanding its function and processing in Alzheimer's disease and normal physiology.